395 related articles for article (PubMed ID: 30900516)
1. Controversies, Consensus, and Collaboration in the Use of
Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Führer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedüs L
Thyroid; 2019 Apr; 29(4):461-470. PubMed ID: 30900516
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for radioiodine therapy of differentiated thyroid cancer.
Luster M; Clarke SE; Dietlein M; Lassmann M; Lind P; Oyen WJ; Tennvall J; Bombardieri E;
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1941-59. PubMed ID: 18670773
[TBL] [Abstract][Full Text] [Related]
3. A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer.
Gulec SA; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Draganescu C; Elisei R; Giovanella L; Grant F; Greenspan B; Hegedüs L; Jonklaas J; Kloos RT; Luster M; Oyen WJG; Smit J; Tuttle RM
Thyroid; 2021 Jul; 31(7):1009-1019. PubMed ID: 33789450
[No Abstract] [Full Text] [Related]
4. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
5. Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.
Forrer F; Fischer GF; Maas O; Giovanella L; Hoffmann M; Iakovou I; Luster M; Mihailovic J; Petranovic Ovčariček P; Vrachimis A; Zerdoud S; Putora PM
Oncology; 2022; 100(2):74-81. PubMed ID: 34788758
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine in the treatment of thyroid cancer.
Van Nostrand D; Wartofsky L
Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
[TBL] [Abstract][Full Text] [Related]
7. Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
Juweid ME; Tulchinsky M; Mismar A; Momani M; Zayed AA; Al Hawari H; Albsoul N; Mottaghy FM
Int J Cancer; 2020 Nov; 147(9):2345-2354. PubMed ID: 32319676
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
Clarke SE
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
[No Abstract] [Full Text] [Related]
9. European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.
Luster M; Aktolun C; Amendoeira I; Barczyński M; Bible KC; Duntas LH; Elisei R; Handkiewicz-Junak D; Hoffmann M; Jarząb B; Leenhardt L; Musholt TJ; Newbold K; Nixon IJ; Smit J; Sobrinho-Simões M; Sosa JA; Tuttle RM; Verburg FA; Wartofsky L; Führer D
Thyroid; 2019 Jan; 29(1):7-26. PubMed ID: 30484394
[TBL] [Abstract][Full Text] [Related]
10. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
Ylli D; Van Nostrand D; Wartofsky L
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):181-197. PubMed ID: 30717901
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer.
Tresoldi AS; Sburlati LF; Rodari M; Schinkelshoek MS; Perrino M; De Leo S; Montefusco L; Colombo P; Arosio M; Lania AGA; Fugazzola L; Chiti A
J Endocrinol Invest; 2014 Aug; 37(8):709-714. PubMed ID: 24844565
[TBL] [Abstract][Full Text] [Related]
12. Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study.
Frangos S; Iakovou IP; Marlowe RJ; Eftychiou N; Patsali L; Vanezi A; Savva A; Mpalaris V; Giannoula EI
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2045-55. PubMed ID: 26231351
[TBL] [Abstract][Full Text] [Related]
13. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
[No Abstract] [Full Text] [Related]
14. Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients.
Frangos S; Iakovou IP; Marlowe RJ; Eftychiou N; Patsali L; Vanezi A; Savva A; Mpalaris V; Giannoula EI
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):185-189. PubMed ID: 27557846
[TBL] [Abstract][Full Text] [Related]
15. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
Sacks W; Wong RM; Bresee C; Braunstein GD
Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
[TBL] [Abstract][Full Text] [Related]
16. Variations in radioiodine ablation: decision-making after total thyroidectomy.
Maas O; Forrer F; Maas M; Panje CM; Blautzik J; Brühlmeier M; Engel-Bicik I; Giovanella L; Haldemann A; Kamel ME; Kneifel S; Rottenburger C; Schaefer N; Walter MA; Weidner S; Putora PM
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):554-560. PubMed ID: 31707428
[TBL] [Abstract][Full Text] [Related]
17. Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer.
Van Nostrand D
Endocrinol Metab Clin North Am; 2017 Sep; 46(3):783-793. PubMed ID: 28760238
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature.
Estorch M; Mitjavila M; Muros MA; Caballero E;
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):195-203. PubMed ID: 30745131
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine remnant ablation: current indications and dosing regimens.
Haugen BR
Endocr Pract; 2012; 18(4):604-10. PubMed ID: 22849876
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective.
Riemann B; Schober O
Minerva Endocrinol; 2009 Mar; 34(1):81-7. PubMed ID: 19209130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
